Real‐Life Perception of Treatment Effectiveness After 24 Weeks of Topical Ruxolitinib in Non‐Segmental Vitiligo: Insights From Patient‐Reported Outcomes
Year: 2026
Type: article
Abstract: The data that support the findings of this study are available from the corresponding author upon reasonable request.
DOI: 10.1111/ijd.70240
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7118739639
